DIABETES OBESITY & METABOLISM

Diabetes, Obesity & Metabolism (ISSN 1462-8902) is a prestigious monthly international journal published by Wiley-Blackwell in the United Kingdom, serving as a leading venue for high-impact research in the fields of diabetes, obesity, and related metabolic disorders. Indexed in the Science Citation Index (SCI) and consistently ranked in the top tiers of the Chinese Academy of Sciences (CAS) journal rankings for medicine and endocrinology/metabolism, the journal maintains a strong reputation for rigorous peer review and high academic standards. While operating under a non-open access model, it attracts a global audience of clinicians, researchers, and healthcare professionals by publishing original studies and comprehensive reviews that span epidemiology, pathophysiological mechanisms, therapeutic strategies, and drug development. Due to its selective editorial process and high rejection rate, the journal is best suited for submissions that demonstrate significant innovation and substantial clinical value, making it a key resource for advancing knowledge in the metabolic health landscape.